News Summary:
MILFORD, Mass., Nov. 16, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today issued its 2023 Environmental, Social, and Governance (ESG) report, highlighting the company's progress towards advancing its sustainability goals. The report also highlights Waters practices that support customers in their sustainability initiatives in areas such as products that consume less energy and reduced packaging material used in shipping.
"At Waters, we are driven to solve some of the most difficult global problems to help fulfill our mission of leaving the world better than we found it," said Dr. Udit Batra, President and CEO of Waters Corporation. "We made solid gains in our overall progress to reduce emissions, increase the use of renewable energy, and have delivered innovative products that have a lower environmental impact. I am also very proud of our progress to become more representative of the society we live in through programs like Waters Student Academy and our global internship program, and by the increase of women in leadership roles. Our focused efforts today are ensuring a more equitable and inclusive culture of tomorrow, allowing us to make a meaningful impact."
2023 ESG Report Highlights
Waters achieved considerable progress against the updated goals it introduced last year as part of its companywide efforts to "leave the world better than we found it," a key principle that directs Waters in its ESG efforts. Progress highlights include:
Environmental
Social
Governance
Recognition of ESG Efforts by Third Parties
Waters received 15 awards in recognition of its ESG efforts since 2022. These include Barron's 2023 100 Most Sustainable Companies U.S. list; Dow Jones Sustainability Index; Newsweek – America's Greenest Companies 2024; USA Today – America's Climate Leaders 2023; 2023 EcoVadis Silver Medal; 2023 Biobase New Leaf Award (China); and U.S. News & World Report – Best Companies to Work for 2023.
Additional Resources
About Waters (www.waters.com)
Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for over 60 years. With approximately 8,000 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.
Waters and Xevo are trademarks of Waters Corporation.
Contact:
Kevin Kempskie
Senior PR Director, Corporate Communications
Waters Corporation
+1-508-482-2814
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$368.16 |
Daily Change: | 7.53 2.09 |
Daily Volume: | 1,302,652 |
Market Cap: | US$21.860B |
November 07, 2024 November 01, 2024 October 10, 2024 October 08, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB